Cargando…

Autism prevalence in China is comparable to Western prevalence

BACKGROUND: Autism prevalence in the West is approximately 1% of school age children. Autism prevalence in China has been reported to be lower than in the West. This is likely due to at least two reasons: (1) most studies in China only included the special school population, overlooking the mainstre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiang, Allison, Carrie, Wei, Liping, Matthews, Fiona E., Auyeung, Bonnie, Wu, Yu Yu, Griffiths, Sian, Zhang, Jie, Baron-Cohen, Simon, Brayne, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394100/
https://www.ncbi.nlm.nih.gov/pubmed/30858963
http://dx.doi.org/10.1186/s13229-018-0246-0
_version_ 1783398826057400320
author Sun, Xiang
Allison, Carrie
Wei, Liping
Matthews, Fiona E.
Auyeung, Bonnie
Wu, Yu Yu
Griffiths, Sian
Zhang, Jie
Baron-Cohen, Simon
Brayne, Carol
author_facet Sun, Xiang
Allison, Carrie
Wei, Liping
Matthews, Fiona E.
Auyeung, Bonnie
Wu, Yu Yu
Griffiths, Sian
Zhang, Jie
Baron-Cohen, Simon
Brayne, Carol
author_sort Sun, Xiang
collection PubMed
description BACKGROUND: Autism prevalence in the West is approximately 1% of school age children. Autism prevalence in China has been reported to be lower than in the West. This is likely due to at least two reasons: (1) most studies in China only included the special school population, overlooking the mainstream school population; and (2) most studies in China have not used contemporary screening and diagnostic methods. To address this, we tested total autism prevalence (mainstream and special schools) in Jilin City, and mainstream school autism prevalence in Jiamusi and Shenzhen cities. METHODS: The study included a three-step process: (1) screening; (2) clinical assessment of ‘screen positives’ plus controls; and (3) research diagnostic assessment of those meeting clinical threshold for concerns at step 2. Prevalence estimates per 10,000 children aged 6–10 years old were weighted for study design using diagnostic criteria applied at the research assessment stage. RESULTS: In Jilin City, 77 cases of autism were identified from a total population of 7258, equating to a prevalence of 108 per 10,000 (95% confidence interval (CI) 89, 130). In Shenzhen City: 21,420 children were screened and 35 cases of autism were identified, resulting in a mainstream prevalence of 42 per 10,000 (95% CI 20–89). In Jiamusi City, 16,358 children were screened, with 10 autism cases being identified, with a mainstream prevalence of 19 per 10,000 (95% CI 10–38). CONCLUSIONS: Results from Jilin City, where both mainstream and special school data were available, revealed a similar prevalence of autism in China to the West, at around 1%. Results from Shenzhen and Jiamusi cities, where only mainstream data were available, prevalence is also in line with Western estimates. In all three cities, new cases of autism were identified by the study in mainstream schools, reflecting current under-diagnosis. Non-significant variation across different cities is seen indicating the need to explore potential variation of autism across diverse Chinese regions with large sample sizes to achieve a fully robust national picture. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13229-018-0246-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6394100
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63941002019-03-11 Autism prevalence in China is comparable to Western prevalence Sun, Xiang Allison, Carrie Wei, Liping Matthews, Fiona E. Auyeung, Bonnie Wu, Yu Yu Griffiths, Sian Zhang, Jie Baron-Cohen, Simon Brayne, Carol Mol Autism Research BACKGROUND: Autism prevalence in the West is approximately 1% of school age children. Autism prevalence in China has been reported to be lower than in the West. This is likely due to at least two reasons: (1) most studies in China only included the special school population, overlooking the mainstream school population; and (2) most studies in China have not used contemporary screening and diagnostic methods. To address this, we tested total autism prevalence (mainstream and special schools) in Jilin City, and mainstream school autism prevalence in Jiamusi and Shenzhen cities. METHODS: The study included a three-step process: (1) screening; (2) clinical assessment of ‘screen positives’ plus controls; and (3) research diagnostic assessment of those meeting clinical threshold for concerns at step 2. Prevalence estimates per 10,000 children aged 6–10 years old were weighted for study design using diagnostic criteria applied at the research assessment stage. RESULTS: In Jilin City, 77 cases of autism were identified from a total population of 7258, equating to a prevalence of 108 per 10,000 (95% confidence interval (CI) 89, 130). In Shenzhen City: 21,420 children were screened and 35 cases of autism were identified, resulting in a mainstream prevalence of 42 per 10,000 (95% CI 20–89). In Jiamusi City, 16,358 children were screened, with 10 autism cases being identified, with a mainstream prevalence of 19 per 10,000 (95% CI 10–38). CONCLUSIONS: Results from Jilin City, where both mainstream and special school data were available, revealed a similar prevalence of autism in China to the West, at around 1%. Results from Shenzhen and Jiamusi cities, where only mainstream data were available, prevalence is also in line with Western estimates. In all three cities, new cases of autism were identified by the study in mainstream schools, reflecting current under-diagnosis. Non-significant variation across different cities is seen indicating the need to explore potential variation of autism across diverse Chinese regions with large sample sizes to achieve a fully robust national picture. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13229-018-0246-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-28 /pmc/articles/PMC6394100/ /pubmed/30858963 http://dx.doi.org/10.1186/s13229-018-0246-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sun, Xiang
Allison, Carrie
Wei, Liping
Matthews, Fiona E.
Auyeung, Bonnie
Wu, Yu Yu
Griffiths, Sian
Zhang, Jie
Baron-Cohen, Simon
Brayne, Carol
Autism prevalence in China is comparable to Western prevalence
title Autism prevalence in China is comparable to Western prevalence
title_full Autism prevalence in China is comparable to Western prevalence
title_fullStr Autism prevalence in China is comparable to Western prevalence
title_full_unstemmed Autism prevalence in China is comparable to Western prevalence
title_short Autism prevalence in China is comparable to Western prevalence
title_sort autism prevalence in china is comparable to western prevalence
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394100/
https://www.ncbi.nlm.nih.gov/pubmed/30858963
http://dx.doi.org/10.1186/s13229-018-0246-0
work_keys_str_mv AT sunxiang autismprevalenceinchinaiscomparabletowesternprevalence
AT allisoncarrie autismprevalenceinchinaiscomparabletowesternprevalence
AT weiliping autismprevalenceinchinaiscomparabletowesternprevalence
AT matthewsfionae autismprevalenceinchinaiscomparabletowesternprevalence
AT auyeungbonnie autismprevalenceinchinaiscomparabletowesternprevalence
AT wuyuyu autismprevalenceinchinaiscomparabletowesternprevalence
AT griffithssian autismprevalenceinchinaiscomparabletowesternprevalence
AT zhangjie autismprevalenceinchinaiscomparabletowesternprevalence
AT baroncohensimon autismprevalenceinchinaiscomparabletowesternprevalence
AT braynecarol autismprevalenceinchinaiscomparabletowesternprevalence